Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232
Abrahimi MS, Elwood M, Lawrenson R, Campbell I, Tin TS (2021) Associated factors and survival outcomes for breast conserving surgery versus mastectomy among New Zealand women with early-stage breast cancer. Int J Environ Res Public Health 18(5):2738. https://doi.org/10.3390/ijerph18052738
Article PubMed PubMed Central Google Scholar
Down SK, Jha PK, Burger A, Hussien MI (2013) Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer. Breast J 19(1):56–63. https://doi.org/10.1111/tbj.12047
Azhdeh S, Kaviani A, Sadighi N, Rahmani M (2020) Accurate estimation of breast tumor size: a comparison between ultrasonography, mammography, magnetic resonance imaging, and associated contributing factors. Eur J Breast Health 17(1):53–61. https://doi.org/10.4274/ejbh.2020.5888
Article PubMed PubMed Central Google Scholar
Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RW, Dixon JM (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26:3248–3258
Wasif N, Garreau J, Terando A, Kirsch D, Mund DF, Giuliano AE (2009) MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg 75:970–975
Lim HI, Choi JH, Yang JH, Han BK, Lee JE, Lee SK (2010) Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma? Breast Cancer Res Treat 119:163
Schoub PK (2018) Understanding indications and defining guidelines for breast magnetic resonance imaging. SA J Radiol 22(2):1353. https://doi.org/10.4102/sajr.v22i2.1353
Article PubMed PubMed Central Google Scholar
Dromain C, Thibault F, Muller S et al (2011) Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol 21(3):565–574
Rudnicki W, Piegza T, Rozum-Liszewska N, Górski M, Popiela TJ, Basta P, Heinze S, Luczynska E (2021) The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts. Pol J Radiol 15(86):e159–e164. https://doi.org/10.5114/pjr.2021.104834
Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, Sapino A, Sasano H, Schnitt S, Sotiriou C, van Diest P, White VA, Lokuhetty D, Cree IA, WHO Classification of Tumours Editorial Board (2020) The 2019 World Health Organization classification of tumours of the breast. Histopathology 77(2):181–185. https://doi.org/10.1111/his.14091
Magny SJ, Shikhman R, Keppke AL (2022) Breast imaging reporting and data system. StatPearls Publishing, Treasure Island
Meucci R, Pistolese CA, Perretta T, Vanni G, Beninati E, Di Tosto F, Serio ML, Caliandro A, Materazzo M, Pellicciaro M, Buonomo OC (2022) Background parenchymal enhancement in contrast-enhanced spectral mammography: a retrospective analysis and a pictorial review of clinical cases. In Vivo 36(2):853–858. https://doi.org/10.21873/invivo.12773
Article PubMed PubMed Central Google Scholar
Onesti JK, Mangus BE, Helmer SD, Osland JS (2008) Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements. Am J Surg 196(6):844–848. https://doi.org/10.1016/j.amjsurg.2008.07.028 (discussion 849–850)
Xing D, Lv Y, Sun B, Xie H, Dong J, Hao C, Chen Q, Chi X (2019) Diagnostic value of contrast-enhanced spectral mammography in comparison to magnetic resonance imaging in breast lesions. J Comput Assist Tomogr 43(2):245–251. https://doi.org/10.1097/RCT.0000000000000832
Patel BK, Garza SA, Eversman S, Lopez-Alvarez Y, Kosiorek H, Pockaj BA (2017) Assessing tumor extent on contrast-enhanced spectral mammography versus full-field digital mammography and ultrasound. Clin Imaging 46:78–84. https://doi.org/10.1016/j.clinimag.2017.07.001
Fallenberg EM, Dromain C, Diekmann F et al (2014) Contrast-enhanced spectral mammography versus MRI: initial results in the detection of breast cancer and assessment of tumor size. Eur Radiol 24:256–264
Lobbes MB, Lalji UC, Nelemans PJ, Houben I, Smidt ML, Heuts E, de Vries B, Wildberger JE, Beets-Tan RG (2015) The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI. J Cancer 6(2):144–150. https://doi.org/10.7150/jca.10705
留言 (0)